These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 35990679)
1. Donor specific HLA antibody in hematopoietic stem cell transplantation: Implications for donor selection. Krummey SM; Gareau AJ Front Immunol; 2022; 13():916200. PubMed ID: 35990679 [TBL] [Abstract][Full Text] [Related]
2. Relevance of donor-specific HLA antibodies in hematopoietic cell transplantation. Tran TH; Heinold A; Spackova M; Pham L; Stelljes M; Dreger P Best Pract Res Clin Haematol; 2024 Sep; 37(3):101576. PubMed ID: 39396260 [TBL] [Abstract][Full Text] [Related]
3. The Role of HLA Antibodies in HLA Mismatched Allogeneic Hematopoietic Stem Cell Transplantation. Zhang X; Wang J; Zhou Z; Zhang Y; Liu H; Tong C; Yu C; Lu Y; Zhao Y; Xiong M; Zhou JR; Juan S; Liu DY; Wei Z; Zhang J; Wu T; Lu DP Clin Transpl; 2014; ():245-50. PubMed ID: 26281152 [TBL] [Abstract][Full Text] [Related]
4. [Effects of preexisting donor-specific HLA antibodies for graft failure in un-manipulated haploidentical hematopoietic stem cell transplantation]. Zhang RL; Zheng XH; Zhou LK; Zhang Y; Chen SL; Yang DL; Jiang EL; Wei JL; Huang Y; Ma QL; Zhai WH; Feng SZ; Han MZ; He Y Zhonghua Xue Ye Xue Za Zhi; 2018 Mar; 39(3):190-195. PubMed ID: 29562462 [No Abstract] [Full Text] [Related]
5. Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation. Ciurea SO; Thall PF; Milton DR; Barnes TH; Kongtim P; Carmazzi Y; López AA; Yap DY; Popat U; Rondon G; Lichtiger B; Aung F; Afshar-Kharghan V; Ma Q; Fernández-Viña M; Champlin RE; Cao K Biol Blood Marrow Transplant; 2015 Aug; 21(8):1392-8. PubMed ID: 25985919 [TBL] [Abstract][Full Text] [Related]
6. The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation. Ciurea SO; Cao K; Fernandez-Vina M; Kongtim P; Malki MA; Fuchs E; Luznik L; Huang XJ; Ciceri F; Locatelli F; Aversa F; Castagna L; Bacigalupo A; Martelli M; Blaise D; Handgretinger R; Roy DC; O'Donnell P; Bashey A; Lazarus HM; Ballen K; Savani BN; Mohty M; Nagler A Bone Marrow Transplant; 2018 May; 53(5):521-534. PubMed ID: 29335625 [TBL] [Abstract][Full Text] [Related]
7. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy. Bailén R; Alenda R; Herruzo-Delgado B; Acosta-Fleitas C; Vallés A; Esquirol A; Fonseca M; Solán L; Sánchez-Vadillo I; Bautista G; Bento L; López-Godino O; Pérez-Martínez A; Torrent A; Zanabili J; Calbacho M; Moreno MÁ; Pascual-Cascón MJ; Guerra-Domínguez L; Chinea A; García-Cadenas I; López-Corral L; Boix-Giner F; López Lorenzo JL; Humala K; Duarte R; Sampol A; Heras I; Vicario JL; Balas A; Oarbeascoa G; Fernández-Caldas P; Anguita J; Kwon M Front Immunol; 2023; 14():1165759. PubMed ID: 37304258 [TBL] [Abstract][Full Text] [Related]
8. High-Dose immunoglobulin Intervention as an effective and simple strategy for donor specific Anti-HLA antibody desensitization in haploidentical transplant. Zhu J; Wang Q; Liu Y; Dong Y; Liang Z; Yin Y; Liu W; Xu W; Sun Y; Wang B; Wang Q; Wang Q; Han N; Ren H; Li Y Int Immunopharmacol; 2023 Jul; 120():110299. PubMed ID: 37201405 [TBL] [Abstract][Full Text] [Related]
9. On the role of HLA antibodies in hematopoietic stem cell transplantation. Brand A; Doxiadis IN; Roelen DL Tissue Antigens; 2013 Jan; 81(1):1-11. PubMed ID: 23216286 [TBL] [Abstract][Full Text] [Related]
10. Donor-Specific Anti-HLA Antibodies in Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: Risk of Graft Failure, Poor Graft Function, and Impact on Outcomes. Bramanti S; Calafiore V; Longhi E; Mariotti J; Crespiatico L; Sarina B; De Philippis C; Nocco A; Santoro A; Castagna L Biol Blood Marrow Transplant; 2019 Jul; 25(7):1395-1406. PubMed ID: 30826463 [TBL] [Abstract][Full Text] [Related]
11. Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT. Yoshihara S; Maruya E; Taniguchi K; Kaida K; Kato R; Inoue T; Fujioka T; Tamaki H; Ikegame K; Okada M; Soma T; Hayashi K; Fujii N; Onuma T; Kusunoki Y; Saji H; Ogawa H Bone Marrow Transplant; 2012 Apr; 47(4):508-15. PubMed ID: 21691261 [TBL] [Abstract][Full Text] [Related]
12. A simple predictor for donor-specific anti-HLA antibody desensitisation in haploidentical haematopoietic stem cell transplantation. Li JM; Zhang ZL; Zhao JL; Wang YQ; Gong SS; Lei H; Wang XF; Hu XX; Cai XH HLA; 2024 Aug; 104(2):e15625. PubMed ID: 39091273 [TBL] [Abstract][Full Text] [Related]
13. Rebound and overshoot of donor-specific antibodies to human leukocyte antigens (HLA) during desensitization with plasma exchanges in hematopoietic progenitor cell transplantation: A case report. Hassan S; West KA; Ward WW; Kanakry JA; Flegel WA Transfusion; 2021 Jun; 61(6):1980-1986. PubMed ID: 33899963 [TBL] [Abstract][Full Text] [Related]
14. Evolution of HLA testing for hematopoietic stem cell transplantation: Importance of the candidate's antibody profile for donor selection. Bettinotti MP Hum Immunol; 2022 Oct; 83(10):721-729. PubMed ID: 35527083 [TBL] [Abstract][Full Text] [Related]
15. Anti-Hla Donor-Specific Antibodies Are Associated to Infection and Not to the Engraftment Rate in Outpatient Haploidentical Hematopoietic Cell Transplantation. Jaime-Pérez JC; Cruz MLR; Mendoza-Ibarra SI; Moncada-Saucedo NK; Gómez-Almaguer D Rev Invest Clin; 2023; 75(5):249-258. PubMed ID: 37918011 [TBL] [Abstract][Full Text] [Related]
16. Bortezomib and Immune Globulin Have Limited Effects on Donor-Specific HLA Antibodies in Haploidentical Cord Blood Stem Cell Transplantation: Detrimental Effect of Persistent Haploidentical Donor-Specific HLA Antibodies. Choe H; Gergis U; Hsu J; Phillips A; Shore T; Christos P; van Besien K; Mayer S Biol Blood Marrow Transplant; 2019 Feb; 25(2):e60-e64. PubMed ID: 30661542 [TBL] [Abstract][Full Text] [Related]
18. Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant. Bailén R; Vicario JL; Solán L; Sánchez-Vadillo I; Herrera P; Calbacho M; Alenda R; López-Lorenzo JL; Humala K; Chinea A; Sánchez-Pina J; Balas A; Moreno MÁ; Arzuaga J; Pradillo V; Dorado N; Oarbeascoa G; Anguita J; Díez-Martín JL; Kwon M Front Immunol; 2021; 12():674658. PubMed ID: 34093576 [TBL] [Abstract][Full Text] [Related]
19. Partially mismatched transplantation and human leukocyte antigen donor-specific antibodies. Gladstone DE; Zachary AA; Fuchs EJ; Luznik L; Kasamon YL; King KE; Brodsky RA; Jones RJ; Leffell MS Biol Blood Marrow Transplant; 2013 Apr; 19(4):647-52. PubMed ID: 23353119 [TBL] [Abstract][Full Text] [Related]
20. High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation. Ciurea SO; de Lima M; Cano P; Korbling M; Giralt S; Shpall EJ; Wang X; Thall PF; Champlin RE; Fernandez-Vina M Transplantation; 2009 Oct; 88(8):1019-24. PubMed ID: 19855248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]